Science 37 Holdings Alpha and Beta Analysis
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Science 37 Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Science 37 over a specified time horizon. Remember, high Science 37's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Science 37's market risk premium analysis include:
Beta 0.57 | Alpha (0.11) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Science |
Science 37 Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Science 37 market risk premium is the additional return an investor will receive from holding Science 37 long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Science 37. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Science 37's performance over market.| α | -0.11 | β | 0.57 |
Science 37 Fundamentals Vs Peers
Comparing Science 37's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Science 37's direct or indirect competition across all of the common fundamentals between Science 37 and the related equities. This way, we can detect undervalued stocks with similar characteristics as Science 37 or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Science 37's fundamental indicators could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Science 37 to competition |
| Fundamentals | Science 37 | Peer Average |
| Return On Equity | -1.19 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Profit Margin | (2.07) % | (1.27) % |
| Operating Margin | (0.60) % | (5.51) % |
| Current Valuation | (21.22 M) | 16.62 B |
| Shares Outstanding | 6.03 M | 571.82 M |
| Shares Owned By Insiders | 16.89 % | 10.09 % |
Science 37 Opportunities
Science 37 Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Science 37 Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Science or other delisted stocks. Alpha measures the amount that position in Science 37 Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Science 37 Upcoming Company Events
As portrayed in its financial statements, the presentation of Science 37's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Science 37's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Science 37's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Science 37. Please utilize our Beneish M Score to check the likelihood of Science 37's management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Science 37
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Correlations Find global opportunities by holding instruments from different markets |